SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.

OBJECTIVE: To develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection Score-Revised (SLESIS-R) and to validate it in a large multicentre lupus cohort. METHODS: We used data from the prospective phase of RELESS...

Descripción completa

Detalles Bibliográficos
Autores: Rua-Figueroa I, García de Yébenes MJ, Martinez-Barrio J, Galindo Izquierdo M, Calvo Alén J, Fernandez-Nebro A, Menor-Almagro R, Carmona L, Tejera Segura B, Tomero E, Freire-González M, Sangüesa C, Horcada L, Blanco R, Uriarte Itzazelaia E, Narváez J, Rosas Gómez de Salazar JC, Gómez-Sabater S, Morales CM, Andreu JL, Segarra VT, Aurrecoechea E, Perez A, Nóvoa Medina J, Salgado E, Lozano-Rivas N, Montilla C, Ruiz-Lucea E, Arevalo M, Iñiguez C, García-Villanueva MJ, Exposito L, Ibáñez-Barceló M, Bonilla G, Carrión-Barberà I, Erausquin C, Fragio Gil JJ, Pecondón A, Toyos FJ, Cobo T, Muñoz-Jiménez A, Oller J, Nolla JM, Pego-Reigosa JM
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Repositorio:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
OAI Identifier:oai:isabial.fundanetsuite.com:p10399
Acceso en línea:https://isabial.portalinvestigacion.com/publicaciones10399
https://lupus.bmj.com/content/11/1/e001096
Access Level:acceso abierto
Palabra clave:epidemiology
lupus erythematosus, systemic
risk factors
id ES_7dbd54db05e88e496e2d5f60b4bba560
oai_identifier_str oai:isabial.fundanetsuite.com:p10399
network_acronym_str ES
network_name_str España
repository_id_str
spelling SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.Rua-Figueroa IGarcía de Yébenes MJMartinez-Barrio JGalindo Izquierdo MCalvo Alén JFernandez-Nebro AMenor-Almagro RCarmona LTejera Segura BTomero EFreire-González MSangüesa CHorcada LBlanco RUriarte Itzazelaia ENarváez JRosas Gómez de Salazar JCGómez-Sabater SMorales CMAndreu JLSegarra VTAurrecoechea EPerez ANóvoa Medina JSalgado ELozano-Rivas NMontilla CRuiz-Lucea EArevalo MIñiguez CGarcía-Villanueva MJExposito LIbáñez-Barceló MBonilla GCarrión-Barberà IErausquin CFragio Gil JJPecondón AToyos FJCobo TMuñoz-Jiménez AOller JNolla JMPego-Reigosa JMepidemiologylupus erythematosus, systemicrisk factorsOBJECTIVE: To develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection Score-Revised (SLESIS-R) and to validate it in a large multicentre lupus cohort. METHODS: We used data from the prospective phase of RELESSER (RELESSER-PROS), the SLE register of the Spanish Society of Rheumatology. A multivariable logistic model was constructed taking into account the variables already forming the SLESIS score, plus all other potential predictors identified in a literature review. Performance was analysed using the C-statistic and the area under the receiver operating characteristic curve (AUROC). Internal validation was carried out using a 100-sample bootstrapping procedure. ORs were transformed into score items, and the AUROC was used to determine performance. RESULTS: A total of 1459 patients who had completed 1 year of follow-up were included in the development cohort (mean age, 49±13 years; 90% women). Twenty-five (1.7%) had experienced =1 severe infection. According to the adjusted multivariate model, severe infection could be predicted from four variables: age (years) =60, previous SLE-related hospitalisation, previous serious infection and glucocorticoid dose. A score was built from the best model, taking values from 0 to 17. The AUROC was 0.861 (0.777-0.946). The cut-off chosen was =6, which exhibited an accuracy of 85.9% and a positive likelihood ratio of 5.48. CONCLUSIONS: SLESIS-R is an accurate and feasible instrument for predicting infections in patients with SLE. SLESIS-R could help to make informed decisions on the use of immunosuppressants and the implementation of preventive measures.BMJ PUBLISHING GROUP2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://isabial.portalinvestigacion.com/publicaciones10399https://lupus.bmj.com/content/11/1/e001096Lupus Science & MedicineISSN: 20538790reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicanteinstname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)Inglésinfo:eu-repo/semantics/openAccessoai:isabial.fundanetsuite.com:p103992026-06-12T10:20:37Z
dc.title.none.fl_str_mv SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
title SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
spellingShingle SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
Rua-Figueroa I
epidemiology
lupus erythematosus, systemic
risk factors
title_short SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
title_full SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
title_fullStr SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
title_full_unstemmed SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
title_sort SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort.
dc.creator.none.fl_str_mv Rua-Figueroa I
García de Yébenes MJ
Martinez-Barrio J
Galindo Izquierdo M
Calvo Alén J
Fernandez-Nebro A
Menor-Almagro R
Carmona L
Tejera Segura B
Tomero E
Freire-González M
Sangüesa C
Horcada L
Blanco R
Uriarte Itzazelaia E
Narváez J
Rosas Gómez de Salazar JC
Gómez-Sabater S
Morales CM
Andreu JL
Segarra VT
Aurrecoechea E
Perez A
Nóvoa Medina J
Salgado E
Lozano-Rivas N
Montilla C
Ruiz-Lucea E
Arevalo M
Iñiguez C
García-Villanueva MJ
Exposito L
Ibáñez-Barceló M
Bonilla G
Carrión-Barberà I
Erausquin C
Fragio Gil JJ
Pecondón A
Toyos FJ
Cobo T
Muñoz-Jiménez A
Oller J
Nolla JM
Pego-Reigosa JM
author Rua-Figueroa I
author_facet Rua-Figueroa I
García de Yébenes MJ
Martinez-Barrio J
Galindo Izquierdo M
Calvo Alén J
Fernandez-Nebro A
Menor-Almagro R
Carmona L
Tejera Segura B
Tomero E
Freire-González M
Sangüesa C
Horcada L
Blanco R
Uriarte Itzazelaia E
Narváez J
Rosas Gómez de Salazar JC
Gómez-Sabater S
Morales CM
Andreu JL
Segarra VT
Aurrecoechea E
Perez A
Nóvoa Medina J
Salgado E
Lozano-Rivas N
Montilla C
Ruiz-Lucea E
Arevalo M
Iñiguez C
García-Villanueva MJ
Exposito L
Ibáñez-Barceló M
Bonilla G
Carrión-Barberà I
Erausquin C
Fragio Gil JJ
Pecondón A
Toyos FJ
Cobo T
Muñoz-Jiménez A
Oller J
Nolla JM
Pego-Reigosa JM
author_role author
author2 García de Yébenes MJ
Martinez-Barrio J
Galindo Izquierdo M
Calvo Alén J
Fernandez-Nebro A
Menor-Almagro R
Carmona L
Tejera Segura B
Tomero E
Freire-González M
Sangüesa C
Horcada L
Blanco R
Uriarte Itzazelaia E
Narváez J
Rosas Gómez de Salazar JC
Gómez-Sabater S
Morales CM
Andreu JL
Segarra VT
Aurrecoechea E
Perez A
Nóvoa Medina J
Salgado E
Lozano-Rivas N
Montilla C
Ruiz-Lucea E
Arevalo M
Iñiguez C
García-Villanueva MJ
Exposito L
Ibáñez-Barceló M
Bonilla G
Carrión-Barberà I
Erausquin C
Fragio Gil JJ
Pecondón A
Toyos FJ
Cobo T
Muñoz-Jiménez A
Oller J
Nolla JM
Pego-Reigosa JM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv epidemiology
lupus erythematosus, systemic
risk factors
topic epidemiology
lupus erythematosus, systemic
risk factors
description OBJECTIVE: To develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection Score-Revised (SLESIS-R) and to validate it in a large multicentre lupus cohort. METHODS: We used data from the prospective phase of RELESSER (RELESSER-PROS), the SLE register of the Spanish Society of Rheumatology. A multivariable logistic model was constructed taking into account the variables already forming the SLESIS score, plus all other potential predictors identified in a literature review. Performance was analysed using the C-statistic and the area under the receiver operating characteristic curve (AUROC). Internal validation was carried out using a 100-sample bootstrapping procedure. ORs were transformed into score items, and the AUROC was used to determine performance. RESULTS: A total of 1459 patients who had completed 1 year of follow-up were included in the development cohort (mean age, 49±13 years; 90% women). Twenty-five (1.7%) had experienced =1 severe infection. According to the adjusted multivariate model, severe infection could be predicted from four variables: age (years) =60, previous SLE-related hospitalisation, previous serious infection and glucocorticoid dose. A score was built from the best model, taking values from 0 to 17. The AUROC was 0.861 (0.777-0.946). The cut-off chosen was =6, which exhibited an accuracy of 85.9% and a positive likelihood ratio of 5.48. CONCLUSIONS: SLESIS-R is an accurate and feasible instrument for predicting infections in patients with SLE. SLESIS-R could help to make informed decisions on the use of immunosuppressants and the implementation of preventive measures.
publishDate 2024
dc.date.none.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://isabial.portalinvestigacion.com/publicaciones10399
https://lupus.bmj.com/content/11/1/e001096
url https://isabial.portalinvestigacion.com/publicaciones10399
https://lupus.bmj.com/content/11/1/e001096
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BMJ PUBLISHING GROUP
publisher.none.fl_str_mv BMJ PUBLISHING GROUP
dc.source.none.fl_str_mv Lupus Science & Medicine
ISSN: 20538790
reponame:r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname:Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
instname_str Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
reponame_str r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
collection r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411686015827968
score 15,812429